Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

FDA says Salix ulcerative colitis Rx approvable

June 26, 1998

Supplemental NDA filed for Rebetron combination therapy

June 19, 1998

Adolor in-licenses Roberts compound for narcotic-induced constipation

June 18, 1998

Genome Therapeutics and Astra Research Center Boston extend alliance

June 17, 1998

ISIS-2302 exhibits promising activity in phase II study for Crohn's disease

June 17, 1998

Shiseido presents antisecretory/antibacterial agents for ulcers

June 16, 1998

Isis and Merck & Co. establish collaboration for hepatitis C

June 15, 1998

Protein Design Labs' human antihepatitis B antibody enters phase IIa

June 12, 1998

Maxamine plus IFN-alpha appears effective and safe in nonresponding HCV patients

June 11, 1998

First European clearance for Eisai's Pariet

June 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...